|
11 Jan 2023 |
Pheno Therapeutics announces worldwide license from UCB to a novel program for neurodegenerative disease
|
|
11 Jan 2023 |
Jasper Therapeutics Announces Development Prioritization of Briquilimab in Chronic Diseases, Including Urticaria and Lower-Risk MDS, and Stem Cell Transplant for Sickle Cell Disease and Other Rare Diseases
|
|
11 Jan 2023 |
Alvotech Initiates Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®
|
|
11 Jan 2023 |
AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets
|
|
11 Jan 2023 |
Hemab Therapeutics Announces First Patient Dosed in Phase 1/2 Study of HMB-001 to Treat Bleeding Disorder Glanzmann Thrombasthenia
|
|
11 Jan 2023 |
Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
|
|
11 Jan 2023 |
Bio4t2 announces first patient infused with CAR-T targeting solid tumors
|
|
11 Jan 2023 |
Genethon Launches Pivotal Clinical Trial of Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease
|
|
11 Jan 2023 |
Avillion announces US approval of AstraZeneca's Airsupra (PT027) as new rescue treatment for asthma
|
|
10 Jan 2023 |
BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development
|
|
10 Jan 2023 |
Tenaya Therapeutics Announces TN-201 IND Clearance and Anticipated 2023 Milestones
|
|
10 Jan 2023 |
Neurocrine Biosciences and Voyager Therapeutics Enter Strategic Collaboration for Development and Commercialization of Voyager’s GBA1 Program and Other Next-Generation Gene Therapies for Neurological Diseases
|
|
10 Jan 2023 |
Kronos Bio Announces Discovery Collaboration with Genentech to Advance Novel Therapies Against Transcriptional Targets in Oncology
|
|
10 Jan 2023 |
BioCryst Reports Initial Clinical Data with Oral Factor D Inhibitor BCX10013 Supporting Development as a Once-daily Treatment for Complement-mediated Diseases
|
|
10 Jan 2023 |
Theriva Biologics Announces Dosing of First Patient in the Investigator Sponsored Phase 1 Trial of VCN-01, an Intravenous Oncolytic Adenovirus, in Patients with Brain Tumors
|
|
10 Jan 2023 |
Coherus Agrees to Acquire Exclusive U.S. Commercial Rights to Eylea® Biosimilar FYB203 from Klinge Biopharma
|
|
10 Jan 2023 |
IDEAYA Announces IND Clearance by U.S. FDA enabling Phase 1 Initiation for First-in-Class PARG Development Candidate IDE161
|
|
10 Jan 2023 |
Avenge Bio Announces Dosing of First Patient in Phase 1/2 Clinical Trial Evaluating AVB-001 for the Treatment of Ovarian Cancer
|
|
10 Jan 2023 |
Immorna Receives IND Clearance to Conduct a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine
|
|
10 Jan 2023 |
Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease
|
